AAAAAA

   
Results: 1-11 |
Results: 11
PENTOXIFYLLINE POTENTIATES IN-VITRO LYMPHOCYTE SUPPRESSION BY GLUCOCORTICOIDS AND IMMUNOSUPPRESSIVE DRUGS
Authors: BRIGGS WA EUSTACE J MATHEW S GIMENEZ LF CHOI M SCHEEL PJ BURDICK J
Citation: Wa. Briggs et al., PENTOXIFYLLINE POTENTIATES IN-VITRO LYMPHOCYTE SUPPRESSION BY GLUCOCORTICOIDS AND IMMUNOSUPPRESSIVE DRUGS, Journal of clinical pharmacology, 38(6), 1998, pp. 561-566
LAPAROSCOPIC RENAL BIOPSY
Authors: GIMENEZ LF MICALI S CHEN RN MOORE RG KAVOUSSI LR SCHEEL PJ
Citation: Lf. Gimenez et al., LAPAROSCOPIC RENAL BIOPSY, Kidney international, 54(2), 1998, pp. 525-529
SUPPRESSION OF DIALYSIS PATIENTS LYMPHOCYTE IL-2R EXPRESSION BY GLUCOCORTICOIDS AND CYCLOSPORINE
Authors: BRIGGS WA GAO ZH XING JJ SCHEEL PJ GIMENEZ LF SAMANIEGO MD CHOI MJ BURDICK JF
Citation: Wa. Briggs et al., SUPPRESSION OF DIALYSIS PATIENTS LYMPHOCYTE IL-2R EXPRESSION BY GLUCOCORTICOIDS AND CYCLOSPORINE, Cytokine, 9(8), 1997, pp. 624-628
DIFFERENTIAL SUPPRESSION OF DIALYSIS PATIENTS LYMPHOCYTE IFN-GAMMA PRODUCTION BY GLUCOCORTICOIDS AND CYCLOSPORINE
Authors: BRIGGS WA GAO ZH XING JJ SCHEEL PJ GIMENEZ LF CHOI MJ BURDICK JF
Citation: Wa. Briggs et al., DIFFERENTIAL SUPPRESSION OF DIALYSIS PATIENTS LYMPHOCYTE IFN-GAMMA PRODUCTION BY GLUCOCORTICOIDS AND CYCLOSPORINE, Cytokine, 8(10), 1996, pp. 804-808
DIFFERENTIAL GLUCOCORTICOID RESPONSIVENESS OF DIALYSIS PATIENTS LYMPHOCYTES
Authors: BRIGGS WA GAO ZH SCHEEL PJ BURDICK JF GIMENEZ LF CHOI MJ
Citation: Wa. Briggs et al., DIFFERENTIAL GLUCOCORTICOID RESPONSIVENESS OF DIALYSIS PATIENTS LYMPHOCYTES, Peritoneal dialysis international, 16(4), 1996, pp. 406-411
LYMPHOCYTE RESPONSIVENESS TO GLUCOCORTICOIDS, CYCLOSPORINE, OR BOTH
Authors: BRIGGS WA GAO ZH GIMENEZ LF SCHEEL PJ CHOI MJ BURDICK JF
Citation: Wa. Briggs et al., LYMPHOCYTE RESPONSIVENESS TO GLUCOCORTICOIDS, CYCLOSPORINE, OR BOTH, Journal of clinical pharmacology, 36(8), 1996, pp. 707-714
SUPPRESSION OF LYMPHOCYTE INTERLEUKIN-2 RECEPTOR EXPRESSION BY GLUCOCORTICOIDS, CYCLOSPORINE, OR BOTH
Authors: BRIGGS WA GAO ZH XING JJ GIMENEZ LF SAMANIEGO MD SCHEEL PJ CHOI MJ BURDICK JF
Citation: Wa. Briggs et al., SUPPRESSION OF LYMPHOCYTE INTERLEUKIN-2 RECEPTOR EXPRESSION BY GLUCOCORTICOIDS, CYCLOSPORINE, OR BOTH, Journal of clinical pharmacology, 36(10), 1996, pp. 931-937
HETEROGENEITY OF DIALYSIS PATIENT LYMPHOCYTE-RESPONSES TO CYCLOSPORINE
Authors: BRIGGS WA GAO ZH XING JJ SCHEEL PJ GIMENEZ LF BURDICK JF
Citation: Wa. Briggs et al., HETEROGENEITY OF DIALYSIS PATIENT LYMPHOCYTE-RESPONSES TO CYCLOSPORINE, Transplantation proceedings, 28(4), 1996, pp. 2063-2065
INTRAVENOUS VERSUS SUBCUTANEOUS DOSING OF EPOETIN ALFA IN HEMODIALYSIS-PATIENTS
Authors: PAGANINI EP ESCHBACH JW LAZARUS JM VANSTONE JC GIMENEZ LF GRABER SE EGRIE JC OKAMOTO DM GOODKIN DA
Citation: Ep. Paganini et al., INTRAVENOUS VERSUS SUBCUTANEOUS DOSING OF EPOETIN ALFA IN HEMODIALYSIS-PATIENTS, American journal of kidney diseases, 26(2), 1995, pp. 331-340
CLINICAL-APPLICATION OF RECOMBINANT ERYTHROPOIETIN IN RENAL DIALYSIS PATIENTS
Authors: GIMENEZ LF SCHEEL PJ
Citation: Lf. Gimenez et Pj. Scheel, CLINICAL-APPLICATION OF RECOMBINANT ERYTHROPOIETIN IN RENAL DIALYSIS PATIENTS, Hematology/oncology clinics of North America, 8(5), 1994, pp. 913
CLINICAL-APPLICATION OF RECOMBINANT ERYTHROPOIETIN IN PREDIALYSIS RENAL-FAILURE
Authors: BRIGGS WA GIMENEZ LF
Citation: Wa. Briggs et Lf. Gimenez, CLINICAL-APPLICATION OF RECOMBINANT ERYTHROPOIETIN IN PREDIALYSIS RENAL-FAILURE, Hematology/oncology clinics of North America, 8(5), 1994, pp. 927
Risultati: 1-11 |